Oxford BioDynamics Plc (LON:OBD – Get Free Report) rose 1.8% on Monday . The stock traded as high as GBX 8.90 ($0.11) and last traded at GBX 8.90 ($0.11). Approximately 490,549 shares were traded during trading, a decline of 41% from the average daily volume of 828,305 shares. The stock had previously closed at GBX 8.74 ($0.11).
Oxford BioDynamics Price Performance
The firm has a market cap of £18.00 million, a PE ratio of -127.14 and a beta of 0.50. The firm has a fifty day simple moving average of GBX 11.28 and a two-hundred day simple moving average of GBX 22.94. The company has a debt-to-equity ratio of 106.34, a quick ratio of 2.80 and a current ratio of 1.79.
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
See Also
- Five stocks we like better than Oxford BioDynamics
- Investing in Construction Stocks
- The Charles Schwab Company Can Hit New Highs
- How to Use Stock Screeners to Find Stocks
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Consumer Discretionary Stocks Explained
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
